MeVis Medical Solutions AG: Adjusting forecast for the current fiscal year

EQS-Ad-hoc: MeVis Medical Solutions AG / Key word(s): Change in Forecast
MeVis Medical Solutions AG: Adjusting forecast for the current fiscal year

31-Jul-2023 / 16:27 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation
(EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Bremen, July 31, 2023 - MeVis Medical Solutions AG (ISIN: DE000A0LBFE4), a
leading provider of medical imaging software, is adjusting its annual
forecast for the current fiscal year based on the preliminary business
figures for the first ten months.

In light of a challenging macroeconomic environment with accelerating
inflation and the ongoing war in Ukraine, MeVis Medical Solutions AG sees
its revenue performance more cautious than before due to current project
developments and subdued expectations in new projects. For fiscal year
2022/2023 (October 1, 2022 to September 30, 2023), revenues are now expected
to decline to between EUR 17.0 million and EUR 17.5 million (previous forecast:
stable revenues of EUR 18.0 million to EUR 18.5 million). EBIT (earnings before
interest and taxes) is expected to be in a range of EUR 3.5 million to EUR 4.0
million in fiscal 2022/2023 in view of the changed assumptions (previous
forecast: decline to EUR 4.5 million to EUR 5.0 million). In addition, earnings
have been strongly impacted by the development of the US dollar/euro
exchange rate since the beginning of the fiscal year.

Contact:

Kirchhoff, Marcus / CEO


End of Inside Information

---------------------------------------------------------------------------

31-Jul-2023 CET/CEST The EQS Distribution Services include Regulatory
Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

---------------------------------------------------------------------------

   Language:       English
   Company:        MeVis Medical Solutions AG
                   Caroline-Herschel-Str. 1
                   28359 Bremen
                   Germany
   Phone:          +49 421 224 95 0
   Fax:            +49 421 224 95 999
   E-mail:         ir@mevis.de
   Internet:       http://www.mevis.de
   ISIN:           DE000A0LBFE4
   WKN:            A0LBFE
   Listed:         Regulated Market in Frankfurt (General Standard);
                   Regulated Unofficial Market in Berlin, Dusseldorf,
                   Hamburg, Munich, Stuttgart, Tradegate Exchange
   EQS News ID:    1692327

End of Announcement EQS News Service
---------------------------------------------------------------------------

1692327 31-Jul-2023 CET/CEST